Jamie Hirata

Genentech, Inc. - San Francisco

1 DNA Way

South San Francisco, CA 94080-4990

United States

SCHOLARLY PAPERS

2

DOWNLOADS

120

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Polatuzumab Vedotin in Combination with Immunochemotherapy in Patients with Previously Untreated DLBCL: A Phase 1b/2 Study

Number of pages: 32 Posted: 22 Nov 2018
Herve Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy Chen, Kathryn Kolibaba, Dan Lu, Mark Yan, Elicia Penuel, Jamie Hirata, Calvin Lee and Jeff P. Sharman
University of Rouen - Department of Haematology, University Hospital of Lille, Washington University in St. Louis, University of Alabama at Birmingham, University of Claude Bernard Lyon 1, University Hospital of Henri-Mondor, APHP, University of Texas at Houston - MD Anderson Cancer Center, Oregon Health and Science University, US Oncology Research, Genentech, Inc. - San Francisco, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and US Oncology Research
Downloads 69 (603,647)

Abstract:

Loading...

B-cell lymphoma, diffuse large B-cell lymphoma, polatuzumab vedotin, antibody drug conjugate, ADC, R-CHOP, CD79b

2.

Safety and Efficacy of Polatuzumab Vedotin + Obinutuzumab for Relapsed/Refractory NHL: A Phase 1b/2 Study

Number of pages: 29 Posted: 08 Mar 2021
Tycel Phillips, Mark Brunvand, Andy I. Chen, James Essell, Annalisa Chiappella, Catherine Diefenbach, Ji Cheng, David Ramies, Jamie Hirata, Franck Morschhauser and Ian W. Flinn
University of Michigan Medical School, Oregon Health and Science University, Oregon Health and Science University, Oncology Hematology Care Inc., Città Della Salute e della Scienza, New York University (NYU) - Laura and Isaac Perlmutter Cancer Center, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, University Hospital of Lille and Sarah Cannon Research Institute/Tennessee Oncology, PLLC
Downloads 51 (699,035)

Abstract:

Loading...